| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artículo científico (es)
- bilimsel makale (tr)
- scienca artikolo (eo)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- artikel ilmiah (id)
- article scientifique (fr)
- বৈজ্ঞানিক নিবন্ধ (bn)
- artículu científicu espublizáu en 2012 (ast)
- наукова стаття, опублікована в серпні 2012 (uk)
- مقالة علمية نشرت في أغسطس 2012 (ar)
- scientific article published on August 2012 (en)
- scientific article published on August 2012 (en-ca)
- scientific article published on August 2012 (en-gb)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - David Horn
- Herwig-Ulf Meier-Kriesche
- Nkechi Azie
- Shun-Ping Quan
|
| rdfs:label
| - The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (en)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (nl)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (ast)
|
| skos:prefLabel
| - The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (en)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (nl)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (ast)
|
| name
| - The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (en)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (nl)
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. (ast)
|
| author
| |
| author
| |
| title
| |
| title
| - The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012 (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/J.DIAGMICROBIO.2012.06.012
|
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
| is about
of | |
| is cites work
of | - Candida albicans induces arginine biosynthetic genes in response to host-derived reactive oxygen species
- Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans
- Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
- Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing
- MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond
- Amphotericin B formulations: a comparative review of efficacy and toxicity
- Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr
- Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts
- Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study
- Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
- PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
- Population-based analysis of invasive fungal infections, France, 2001-2010.
- Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome
- Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai
- Eosinophil deficiency compromises lung defense against Aspergillus fumigatus
- Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults
- Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum
- O-mannosylation in Candida albicans enables development of interkingdom biofilm communities.
- Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms
- The fungal UPR: a regulatory hub for virulence traits in the mold pathogen Aspergillus fumigatus.
- Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)